Skip to main content
Clinical Trials/CTRI/2019/03/018138
CTRI/2019/03/018138
Completed
Phase 4

A Clinical study to evaluate the effectiveness of study face wash in subjects with acne vulgaris(Mukhadooshika).

Ramaiah Indic Specialty Ayurveda0 sites50 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L709- Acne, unspecified
Sponsor
Ramaiah Indic Specialty Ayurveda
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 2, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ramaiah Indic Specialty Ayurveda

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female volunteers, with age 18â??45 years
  • 2\. Subjects willing and able to provide informed consent voluntarily
  • 3\. Subjects with facial acne grade of I\-III as assessed by Investigatorâ??s Global Assessment
  • 4\. Willing to maintain the investigational product use throughout the study.
  • 5\. Subjects who have not undergone any skin therapy in last 3 months
  • 6\. Subjects with no known allergy to any of the test ingredients
  • 7\. Women using oral contraceptives must have been doing so for at least 6 consecutive months prior to entering the study, and are required to continue with the same brand throughout the study period
  • 8\. Subjects who are willing to refrain from using any skin care product other than the investigational product, like, moisturizers, face washes and face creams, for the duration of the study
  • 9\. Subjects willing and able to comply with all trial requirements
  • 10\. Laboratory workup within normal limits; including complete hemogram, glucose, blood urea nitrogen, creatinine, liver function test, lipid profile, thyroid\-stimulating hormone, urine pregnancy test

Exclusion Criteria

  • 1\. Subjects who have skin diseases like psoriasis, atopic dermatitis etc. at the time of screening
  • 2\. Subject with chronic systemic illnesses or treatment that can affect skin health eg. Polycystic ovarian disease
  • 3\. Subjects on oral medications or suffering from chronic illness which will compromise the study
  • 4\.Women who have stopped using oral contraceptives less than three months prior to entering the study
  • 5\. Subjects who have participated in a similar investigation in the past four weeks
  • 6\. Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials